Free Trial
NASDAQ:STAA

STAAR Surgical (STAA) Stock Price, News & Analysis

STAAR Surgical logo
$29.89 +0.81 (+2.79%)
Closing price 04:00 PM Eastern
Extended Trading
$29.83 -0.06 (-0.20%)
As of 07:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About STAAR Surgical Stock (NASDAQ:STAA)

Advanced

Key Stats

Today's Range
$28.92
$29.93
50-Day Range
$17.47
$33.34
52-Week Range
$15.59
$35.87
Volume
1.13 million shs
Average Volume
1.07 million shs
Market Capitalization
$1.49 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$27.81
Consensus Rating
Hold

Company Overview

STAAR Surgical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
44th Percentile Overall Score

STAA MarketRank™: 

STAAR Surgical scored higher than 44% of companies evaluated by MarketBeat, and ranked 679th out of 871 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    STAAR Surgical has received a consensus rating of Hold. The company's average rating score is 2.09, and is based on no strong buy ratings, 3 buy ratings, 6 hold ratings, and 2 sell ratings.

  • Downside Risk

    STAAR Surgical has a consensus price target of $27.81, representing about 7.0% downside from its current price of $29.91.

  • Amount of Analyst Coverage

    STAAR Surgical has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about STAAR Surgical's stock forecast and price target.
  • Earnings Growth

    Earnings for STAAR Surgical are expected to grow in the coming year, from ($0.03) to $0.22 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of STAAR Surgical is -69.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of STAAR Surgical is -69.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    STAAR Surgical has a P/B Ratio of 4.22. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about STAAR Surgical's valuation and earnings.
  • Percentage of Shares Shorted

    19.69% of the float of STAAR Surgical has been sold short.
  • Short Interest Ratio / Days to Cover

    STAAR Surgical has a short interest ratio ("days to cover") of 4.88.
  • Change versus previous month

    Short interest in STAAR Surgical has recently decreased by 12.48%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    STAAR Surgical does not currently pay a dividend.

  • Dividend Growth

    STAAR Surgical does not have a long track record of dividend growth.

  • News Sentiment

    STAAR Surgical has a news sentiment score of 0.85. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for STAAR Surgical this week, compared to 6 articles on an average week.
  • Search Interest

    Only 3 people have searched for STAA on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Net Insider Buying

    Over the last three months, insiders have purchased a net $12,266,249.00 in company stock, which represents 0.8237% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, STAAR Surgical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $12,266,249.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    39.90% of the stock of STAAR Surgical is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    96.70% of the stock of STAAR Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about STAAR Surgical's insider trading history.
Receive STAA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

STAA Stock News Headlines

Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel
See More Headlines

STAA Stock Analysis - Frequently Asked Questions

STAAR Surgical's stock was trading at $23.09 on January 1st, 2026. Since then, STAA stock has increased by 29.5% and is now trading at $29.91.

STAAR Surgical Company (NASDAQ:STAA) announced its quarterly earnings results on Wednesday, May, 13th. The medical instruments supplier reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.05. STAAR Surgical's revenue was up 119.6% compared to the same quarter last year.
Read the conference call transcript
.

STAAR Surgical's board authorized a stock buyback program on Friday, May 16th 2025, which allows the company to repurchase $30,000,000 in outstanding shares, according to EventVestor. This means that the company could repurchase up to 3.2% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company's leadership believes its shares are undervalued.

STAAR Surgical subsidiaries include these companies: Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD.

Top institutional shareholders of STAAR Surgical include American Capital Management Inc. (1.76%), Dimensional Fund Advisors LP (1.65%), Principal Financial Group Inc. (0.49%) and Bank of New York Mellon Corp (0.47%). Insiders that own company stock include Broadwood Partners, LP, Aimee S Weisner, Arthur C Butcher and Elizabeth Yeu Lin.
View institutional ownership trends
.

Shares of STAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that STAAR Surgical investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), Palo Alto Networks (PANW) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
5/13/2026
Today
5/29/2026
Next Earnings (Estimated)
8/12/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED/DENTAL - SUPP
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:STAA
CIK
718937
Employees
1,211
Year Founded
1982

Price Target and Rating

High Price Target
$40.00
Low Price Target
$13.00
Potential Upside/Downside
-7.0%
Consensus Rating
Hold
Rating Score (0-4)
2.09
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.43)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$80.45 million
Net Margins
-7.24%
Pretax Margin
-6.74%
Return on Equity
3.31%
Return on Assets
2.55%

Debt

Debt-to-Equity Ratio
0.09
Current Ratio
5.12
Quick Ratio
4.31

Sales & Book Value

Annual Sales
$239.44 million
Price / Sales
6.22
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$7.08 per share
Price / Book
4.22

Miscellaneous

Outstanding Shares
49,790,000
Free Float
29,923,000
Market Cap
$1.49 billion
Optionable
Optionable
Beta
1.20

Social Links

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:STAA) was last updated on 5/29/2026 by MarketBeat.com Staff.
From Our Partners